Skip to content

BMY vs LLY: Dividend Comparison

BMY$60.78
Bristol Myers Squibb Co
Health Care
vs
LLY$1,045.09
ELI LILLY & Co
Health Care

Dividend data as of

Bristol Myers Squibb Co (BMY) and ELI LILLY & Co (LLY) are both in the Health Care sector, making them natural rivals for dividend investors. BMY offers a significantly higher 4.09% yield compared to LLY's 0.59%, a gap of 3.51%. For dividend growth, LLY leads with a 5-year CAGR of 23.8% versus BMY's 14.0%. LLY holds the edge in dividend safety with a "Safe" rating. LLY is a Dividend Contender with 11 years of consecutive increases.

Verdict

Best for Income
BMY
Higher yield at 4.09%
Best for Growth
LLY
5yr CAGR of 23.8%
Best for Safety
LLY
Rated "Safe"
Metric
Price
$60.78
$1,045.09
Dividend Yield
4.09%
0.59%
Annual Dividend
$2.49
$6.00
5yr Div CAGR
14.0%
23.8%
3yr Div CAGR
20.4%
15.2%
Consecutive Years
0
11
Payout Ratio
71.97%
26.14%
P/E Ratio
Market Cap
Income on $10k
$409/yr
$59/yr

Yield Analysis

BMY
4.09%
LLY
0.59%

BMY yields 3.51% more than LLY. In dollar terms, BMY pays $2.49/share vs LLY's $6.00/share annually.

Dividend Growth

BMY 5yr CAGR
14.0%
accelerating
LLY 5yr CAGR
23.8%
decelerating

BMY: Dividend growth is accelerating — the 3-year CAGR of 20.4% exceeds the 5-year rate of 14.0% and the 10-year rate of 9.0%.

LLY: Dividend growth is slowing — the 3-year CAGR of 15.2% trails the 5-year rate of 23.8% and the 10-year rate of 16.4%.

Dividend Safety

BMY
Moderate
Payout Ratio72%
LLY
Safe
Payout Ratio26%

BMY: The payout ratio of 72% is moderate. The dividend is currently covered by earnings but leaves less room for growth. Earnings cover the dividend 1.4x.

LLY: The payout ratio of 26% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 3.8x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
BMY
LLY
$10,000
$409/yr
$59/yr
$50,000
$2,046/yr
$293/yr
$100,000
$4,091/yr
$585/yr

What does $10,000 buy in BMY vs LLY today?

At $60.77 per share, $10,000 buys about 164.5 shares of Bristol Myers Squibb Co (BMY). Each share pays $2.49 per year in dividends, so the position starts out generating roughly $410 per year — about $34 a month.

At $1045.09 per share, $10,000 buys about 9.6 shares of ELI LILLY & Co (LLY). Each share pays $6.00 per year in dividends, so the position starts out generating roughly $57 per year — about $5 a month.

BMY is the larger income stream from day one: $352 per year more on the same $10,000 invested.

What could $10,000 of BMY or LLY income look like in 10 years?

Bristol Myers Squibb Co (BMY) has raised its dividend about 14.0% a year over the past five years. If that pace held, the $409 per year that $10,000 generates today at the current 4.09% yield would reach $1,513 per year by 2036 — a 15.1% yield on the original cost.

ELI LILLY & Co (LLY) has raised its dividend about 23.8% a year over the past five years. If that pace held, the $59 per year that $10,000 generates today at the current 0.59% yield would reach $497 per year by 2036 — a 5.0% yield on the original cost.

On those trailing rates, BMY pays more in 2036: $1,513 versus $497 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would LLY's dividend growth overtake BMY's higher yield?

ELI LILLY & Co (LLY) yields less today (0.59% vs 4.09%) but has grown its dividend faster — 23.8% vs 14.0% a year over the past five years. If both trends continued, a $10,000 position in LLY would start out-earning the same position in BMY around 2050 (roughly 24 years from now), paying about $9,930 per year at the crossover. Before that point, BMY pays more each year; after it, the gap compounds in LLY's favor.

Can BMY and LLY afford their dividends?

Bristol Myers Squibb Co (BMY) earns $3.46 per share against $2.49 paid out in dividends — 1.4x coverage (a 72% payout ratio).

ELI LILLY & Co (LLY) earns $22.98 per share against $6.00 paid out in dividends — 3.8x coverage (a 26% payout ratio).

LLY's wider coverage leaves more cushion if earnings dip. As a rule of thumb, coverage below about 1.5x (a payout ratio above ~65%) is where a dividend starts to look stretched — worth watching for BMY if earnings weaken.

Which fits an early-retirement income portfolio better, BMY or LLY?

For income you need right now, Bristol Myers Squibb Co (BMY) leads: $100,000 invested today pays about $341 a month at the current 4.09% yield, versus $49 a month from ELI LILLY & Co (LLY) at 0.59%.

With a decade or more before the income is needed, LLY's faster dividend growth (23.8% vs 14.0% a year) matters more than the starting yield — raises compound into the larger paycheck over time.

On consistency: LLY has raised its dividend 11 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $2,259/yr in BMY vs $527/yr in LLY by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Track BMY and LLY in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.